Previous epidemiological studies have demonstrated that traditional CVD risk factors do not fully explain these differences. 5, 9, 12 Other studies have also suggested that these race/ethnic differences are only partially explained by differences in socioeconomic status (SES), psychosocial factors as well as access to healthcare. [13] [14] [15] [16] [17] These findings highlight the potentially important role of ancestry-related genetic factors in the development of subclinical atherosclerosis. 5, 12 However, the association of genetic ancestry with subclinical atherosclerosis is not fully understood probably because most of these studies relied on self-reported race/ethnicity or skin reflectance 18, 19 which are measurements that do not take into account for genetic heterogeneity within each racial/ethnic group; ignoring such heterogeneity can conflate the contributions of genetic, SES, or environmental factors. Objective-To determine whether genetic ancestry was associated with subclinical atherosclerosis measures after adjustment for traditional cardiovascular disease risk factors, inflammatory marker, socioeconomic status, and psychosocial factors in a large admixed African American population. Approach and Results-Participants were drawn from the Jackson Heart Study. Participant's percent of European ancestry (PEA) was estimated based on 1747 genetic markers using HAPMIX. Association of PEA with peripheral arterial disease and common carotid intima-media thickness were investigated among 2168 participants and with coronary artery calcification >0 and abdominal aortic calcification >0 among 1139 participants. The associations were evaluated using multivariable regression models. Our results showed that a 1 SD increase in PEA was associated with a lower peripheral arterial disease prevalence after adjusting for age and sex (prevalence ratio=0. 
S ubclinical atherosclerosis measures, including peripheral arterial disease (PAD), carotid intima-media thickness (CIMT), coronary artery calcification (CAC), and abdominal aortic calcification (AAC) have been shown to be strong predictors of cardiovascular disease (CVD) events in numerous studies. [1] [2] [3] Several studies have reported substantial racial/ethnic differences in prevalence of subclinical atherosclerosis between African Americans and European Americans. Despite a worse CVD risk factors profile compared with European Americans, African Americans have substantially lower prevalence of CAC and AAC. [4] [5] [6] [7] In contrast, African Americans have relatively higher mean of CIMT and prevalence of PAD than European Americans. [8] [9] [10] [11] among the most genetic and culturally heterogeneous group in the Unites States, with mixed ancestry mainly from West Africa and Europe. 23 Recent advances in genomics research have allowed to precisely estimate individual genetic ancestry using ancestry informative markers 23 or a large set of random markers. 24 Genetic ancestry can be a useful tool in determining whether ancestry-related genetic factors or nongenetic factors driving the disparities in subclinical atherosclerosis. Furthermore, genetic ancestry associations can be used as a precursor to admixture mapping for uncovering genes that contribute to subclinical atherosclerosis. 25 However, only a limited number of studies examined the association between genetic ancestry and subclinical atherosclerosis in African Americans and they reported mixed results. [26] [27] [28] [29] One study reported significant associations of European genetic ancestry with CAC and common CIMT (cCIMT) among selfreported African Americans. 26 In contrast, another study which involved younger participants found no significant association of African ancestry with CAC. 28 Reiner et al 27 also found that African ancestry was not significantly associated with cCIMT among elderly African Americans. Potential reasons for these mixed findings, in addition to age differences, include the use of relatively small sample sizes of African Americans and relatively small number of ancestry informative markers to accurately estimate genetic ancestry. [26] [27] [28] Furthermore, only 1 study has investigated the association of genetic ancestry with PAD in African Americans and reported an inverse but nonsignificant association, 29 and no study looked at the relationship between AAC and genetic ancestry. In addition, some of these studies have not accounted for a range of nongenetic risk factors, including SES and psychosocial factors. Therefore, this study attempts to improve our understanding whether ancestry-related genetic factors play an important role in subclinical atherosclerosis by overcoming some of the limitations of previous studies, replicating earlier analysis with a large sample of African American while controlling for a wider range of nongenetic risk factors, and examining for the first time the association of genetic ancestry and AAC.
In this study, we used the Jackson Heart Study (JHS) to determine whether genetic ancestry was associated with subclinical atherosclerosis measures after adjustment for traditional CVD risk factors, inflammatory marker as well as SES and psychosocial factors.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement. Table 1 shows comparisons of baseline demographic and clinical characteristics of JHS participants across the percent of European ancestry (PEA) levels. Among the 2168 self-identified African American participants, the average age was 54 and 39% were men. On average, the participants had a median of 16% European ancestry (interquartile range=12%-22%). Across the levels of PEA, participants were similar in sex; prevalence of diabetes mellitus; smoking; and levels of low-density lipoprotein, high-density lipoprotein, and triglycerides (all P>0.05). However, those in the highest levels of PEA (>90% PEA) had lower prevalence of hypertension, lower mean body mass index, mean systolic blood pressure, mean high-sensitivity C-reactive protein, mean cCIMT, and mean age (all P<0.05). Furthermore, those in the highest levels of PEA had higher income and higher education compared with those in the lowest level of PEA (both P<0.001), but none of the psychosocial variables were significant. Table 2 presents the prevalence ratio (PR) and 95% confidence interval for PAD per SD increase in PEA. The restricted cubic spline analysis indicated that the association between PEA and PAD was approximately linear (Figure [A] ). PEA was significantly and inversely related with PAD as shown in (Table 3) .
Results
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Discussion
In this study of a large sample of African Americans, we found evidence that genetic ancestry is associated with measures of subclinical atherosclerosis. We also found European ancestry was inversely associated with prevalence of PAD in African Americans. This association was attenuated, but remained marginally significant when we fully adjusted for traditional CVD risk factors, inflammatory marker, SES, and psychosocial factors. We also identified significant nonlinear associations of PEA with CAC and AAC, which shows that participants with the lowest European ancestry had a lower prevalence of CAC and AAC. Adjustment for traditional CVD risk factors, inflammatory marker, SES, and psychosocial factors did not explain the observed associations. The apparent nonlinear associations of PEA with CAC and AAC suggest that unmeasured risk factors and interaction with genetic factors could play a more important role than genetic effects in this sample of African Americans. However, we did not find significant association between genetic ancestry and cCIMT. Overall, our findings suggest that unmeasured risk factors and ancestry-related genetic differences may contribute to the distribution of subclinical atherosclerosis in African Americans. Few prior studies have examined the associations between genetic ancestry and subclinical atherosclerosis in African Americans. Although nonsignificant, Allison et al 29 observed inverse association between European ancestry and PAD among 712 African Americans of the Multi-Ethnic Study of Atherosclerosis (MESA); in contrast, in our study, this association was marginally significant after adjusting for traditional CVD risk factors, inflammatory marker, SES, and psychosocial factors. Our findings are also in line with previous studies that reported a significant association between European ancestry and CAC. 26, 30 For example, Wassel 26 et al reported that PEA was linearly, positively associated with the prevalence of CAC among 712 African Americans in the MESA study, suggesting genetic components to CAC in African Americans. Unlike their findings, however, our results showed a dose-response relationship between PEA and CAC such that only participants with the lowest level of PEA had significantly lower CAC prevalence, indicating unknown risk factors and gene-environment interactions could play a more important role than genetic factors in this cohort. We did not observe a significant association between cCIMT and European ancestry in our study, which is similar to 1 study that found no association between African ancestry and cCIMT among elderly African Americans of the Cardiovascular Health Study (CHS). 27 However, another study reported a linear, negative association between PEA and cCIMT independent of CVD risk factors and SES in African Americans of the MESA study, suggesting genetic influence on cCIMT. 26 It is possible that differences in regional origin, sample size, estimation of ancestry, and methodological approaches in the measurement of cCIMT could have attributed to the discrepancies between these studies. 26, 27, 31 Our study was also the first to look at PEA and AAC and displayed a similar pattern of association with those of CAC. There is no literature on genetic ancestry and AAC with which to compare our results, but our findings are in line with 1 study that reported a lower prevalence of AAC in African Americans than that in whites using self-reported race/ethnicity. 7 In aggregate, the current and these previous studies provide evidence in support to the ancestry-related differences in the distribution of subclinical atherosclerosis within African Americans. Explanations for the differences in associations between PEA and the different subclinical atherosclerosis measures remain unclear. However, these findings indicate that distinct pathophysiological processes or risk factors might be involved in different ethnic groups for the different atherosclerosis measures, which might explain some of the observed differences by genetic ancestry. 5, 12, 18, 32, 33 Evidence suggests that hypertension, diabetes mellitus, and obesity are more prevalent in African Americans or in those with low PEA and that they are strong and independent risk factors for PAD and cCIMT. 12, 32, 33 Our results showed that association between PEA and PAD remained significant after adjusting for these CVD risk factors and inflammatory marker. This association attenuated, but persisted after additional adjustment for SES and psychosocial factors. This suggests that unmeasured risk factors may play a role in the pathogenesis of PAD. Several studies have found higher level of novel risk factors, such as interleukin-6, fibrinogen, d-dimer, and homocysteine, were associated with increased odds of PAD among African Americans. 12, [33] [34] [35] The same studies have also indicated that traditional or novel CVD risk factors do not entirely explain the high prevalence of PAD in African Americans, suggesting genetic components to the development of PAD. 12, [32] [33] [34] [35] In fact, a recent study found a novel region in chromosome 11 that was associated with high PAD in African Americans. 36 Thus, it is probably the interplay of traditional CVD and novel risk factors, SES, and genetic factors could explain the differences in PAD among African Americans.
Although African Americans have worse CVD risk factor profiles, we observed significantly lower prevalence of CAC and AAC in African Americans with the lowest PEA even after adjustment for traditional CVD risk factors, inflammatory marker, SES, and psychosocial factors. This finding is consistent with a large body of evidence reporting that standard CVD risk factors do not fully explain the ancestry-related differences in CAC and AAC. 5, 26, 37 It is highly possible that the observed differences in CAC and AAC could be because of nongenetic factors that were not accounted for in our study. Several previous studies have indicated that unmeasured risk factors, such as bone density, vitamin D, calcium metabolism, and other environmental factors, might play an important role in the development of CAC and AAC. 5, 26, [37] [38] [39] [40] Indeed, bone density has been found to be inversely related with CAC; African Americans have higher levels of bone density than whites. 38 Other studies have also highlighted the association of lower vitamin D with CAC. 5, 39, 40 Alternatively, it is also possible that genetic factors may contribute to CAC in African Americans. 26, 30, 41 For example, recent admixture mapping of CAC in African Americans identified several genomic regions in which excess European ancestry was associated with higher levels of CAC. 41 Previous studies have also identified that the 9p21 region was associated with CAC in predominantly European-derived populations. 42, 43 Taken together, the apparent lower level of CAC and AAC in participants with the lowest PEA in our study indicates the importance of other unmeasured risk factors and gene by environment interactions than genetic effects. PAD defined as ankle-brachial index ≤0.99. SD, 9.0%. Model 1, adjusted for demographic: age and sex; model 2, adjusted for model 1 and traditional CVD risk factors: body mass index, current smoking, diabetes mellitus, hypertension, fasting plasma glucose, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and high-sensitivity C-reactive protein; model 3, adjusted for model 1 and SES and psychosocial factors: household annual income, education, perceived global stress, and every day, and lifetime discrimination; and model 4, adjusted for all the covariates.
CI indicates confidence interval; CVD, cardiovascular disease; PAD, peripheral arterial disease; PEA, percent of European ancestry; PR, prevalence ratio; and SES, socioeconomic status.
Our study has some limitations which should be taken into consideration when interpreting the results. First, although we adjusted for several known risk factors of subclinical atherosclerosis, it is possible that residual confounding may have affected our results. Future research is needed to determine whether unmeasured risk factors and gene-environment interactions can help account for the observed associations in African Americans. Second, our sample came from a single site of Jackson, MS, may not be generalizable to the general population of African Americans across the United States. Furthermore, the PEA in our study was skewed toward lower values and few participants had ≥25% European ancestry, thus, we were unable to examine the full range of PEA associations with subclinical atherosclerosis measures. Fourth, the time lag between evaluation of some of the baseline covariates (eg, SES, current smoking, and psychosocial factors) and measures of CAC and AAC in Examination 2, which could have influenced the associations of PEA with CAC and AAC. Finally, the cross-sectional design of our study limits our ability to draw conclusions whether genetic ancestry predicts subclinical atherosclerosis independent of nongenetic factors. Future studies are warranted to replicate our findings, perhaps using larger sample sizes of African Americans, with a full range of ancestry to overcome any chance findings might present in our analyses.
Despite these limitations, our study used a large well-characterized sample of African Americans and hence had greater statistical power than prior studies that examined the association of PEA with subclinical atherosclerosis. Moreover, PEA in our study was estimated based on a large number of ancestry informative markers, which minimized the errors associated with estimating genetic ancestry compared with prior studies. Our study also benefits from the state-of-the-art measures of subclinical atherosclerosis and availability of a wide range of important confounding covariates for adjustment. Figure. A, Dose-response relationship between percent of European ancestry (PEA) and peripheral arterial disease (PAD). The prevalence ratios (PRs) were based on restricted cubic splines (RCS) at knots of 5th, 35th, 65th, and 95th percentiles. The reference was set at the 50th percentile (16%) of the European ancestry distribution. The solid line indicates the PR adjusted for age, sex, traditional cardiovascular disease (CVD) risk factors, inflammatory maker, socioeconomic status, and psychosocial factors. B, Dose-response relationship between PEA and common carotid intima-media thickness (cCIMT). The mean differences were based on RCS at knots of 5th, 35th, 65th, and 95th percentiles. The reference was set at the 50th percentile (16%) of the European ancestry distribution. The solid line indicates the mean difference adjusted for age, sex, traditional CVD risk factors, inflammatory maker, socioeconomic status, and psychosocial factors. C, Dose-response relationship between PEA and coronary artery calcium (CAC). The PRs were based on RCS at knots of 5th, 35th, 65th, and 95th percentiles. The reference was set at the 50th percentile (16%) of the European ancestry distribution. The solid line indicates the PR adjusted for age, sex, traditional CVD risk factors, inflammatory maker, socioeconomic status, and psychosocial factors. D, Dose-response relationship between PEA and abdominal aortic calcification (AAC). The PRs were based on RCS at knots of 5th, 35th, 65th, and 95th percentiles. The reference was set at the 50th percentile (16%) of the European ancestry distribution. The solid line indicates the PR adjusted for age, sex, traditional CVD risk factors, inflammatory maker, socioeconomic status, and psychosocial factors. A-D, Dashed lines represent its 95% confidence intervals.
Additionally, our study is also the first to show the association of AAC with genetic ancestry. Finally, our study significantly contributes to the limited body of literature on genetic ancestry and subclinical atherosclerosis among African Americans, which often used skin reflectance as a surrogate for genetic ancestry or not enough large number of ancestry informative markers to determine ancestry with precision. 18, 19, 27 Furthermore, our findings provide background for pursing further studies on the role of genetic factors in subclinical atherosclerosis processes.
Conclusions
In conclusions, genetic ancestry was associated with subclinical atherosclerosis in a large sample of African Americans. We found significantly lower prevalence of CAC and AAC in participants with the lowest European ancestry, which seems not fully explained by traditional CVD risk factors, SES, and psychosocial factors. We also found that greater European ancestry was associated with lower prevalence of PAD although the association was attenuated after adjusting for SES and psychosocial factors. Our findings suggest that unmeasured risk factors and interacting with genetic determinants might play an important role to the distribution of subclinical atherosclerosis in African Americans. Future studies are needed to validate these findings and explore gene-environment interactions to better understand the complex biological mechanisms and to reduce ancestry-related disparities in subclinical atherosclerosis. Model 1, adjusted for demographic: age and sex; model 2, adjusted for model 1 and traditional CVD risk factors: body mass index, current smoking, diabetes mellitus, hypertension, fasting plasma glucose, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and high-sensitivity C-reactive protein; model 3, adjusted for model 1 and SES and psychosocial factors: household annual income, education, perceived global stress, and every day and lifetime discrimination; and model 4, adjusted for all the covariates.
AAC indicates abdominal aortic calcification; CAC, coronary artery calcium; cCIMT, common carotid intima-media thickness; CI, confidence interval; CVD, cardiovascular disease; PEA, percent of European ancestry; and SES, socioeconomic status.
